Types of Tumors
Pipeline Molecules 1
The compounds and their uses mentioned on this website are investigational and have not been approved by the US Food and Drug Administration. Efficacy and safety have not been established. The information presented should not be construed as a recommendation for use. The relevance of findings in preclinical studies to humans is currently being evaluated.
Raf/MEK dual inhibitor
aDeveloped in collaboration with Seattle Genetics. bTensha acquisition. cDeveloped in collaboration with Array BioPharma. dDeveloped in collaboration with Exelixis. eDeveloped in collaboration with Chugai. fDeveloped in collaboration with BioNTech. gJoint project with AbbVie.
1. Roche full-year results 2017 presentation. www.roche.com/dam/jcr:8c13fdde-ea51-431d-9eb1-b6e0a530930f/en/irp180201.pdf.
Accessed February 7, 2018.